DrugPatentWatch Database Preview
Email this page to a colleague» See Plans and Pricing
« Back to Dashboard
Foretinib is an investigational drug.
There have been 8 clinical trials for Foretinib. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2006.
The most common disease conditions in clinical trials are Carcinoma, Breast Neoplasms, and Lung Neoplasms. The leading clinical trial sponsors are GlaxoSmithKline, NCIC Clinical Trials Group, and [disabled in preview].
Recent Clinical Trials for Foretinib
|A Study to Evaluate Foretinib in Subjects With Non-Small-Cell Lung Cancer||GlaxoSmithKline||Phase 2|
|Study of Foretinib in Combination With Lapatinib in Patients With Metastatic Breast Cancer||NCIC Clinical Trials Group||Phase 1/Phase 2|
|A Study of Foretinib in Patients With Recurrent/Metastatic Breast Cancer||NCIC Clinical Trials Group||Phase 2|